These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 7373538)

  • 1. Biological disposition of sodium dichloroacetate in animals and humans after intravenous administration.
    Lukas G; Vyas KH; Brindle SD; Le Sher AR; Wagner WE
    J Pharm Sci; 1980 Apr; 69(4):419-21. PubMed ID: 7373538
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolic effects and pharmacokinetics of intravenously administered dichloroacetate in humans.
    Wells PG; Moore GW; Rabin D; Wilkinson GR; Oates JA; Stacpoole PW
    Diabetologia; 1980 Aug; 19(2):109-13. PubMed ID: 7418965
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma concentrations and metabolic effects of intravenous sodium dichloroacetate.
    Curry SH; Chu PI; Baumgartner TG; Stacpoole PW
    Clin Pharmacol Ther; 1985 Jan; 37(1):89-93. PubMed ID: 3965240
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dichloroacetate tissue concentrations and its relationship to hypolactatemia and pyruvate dehydrogenase activation.
    Evans OB
    Biochem Pharmacol; 1982 Oct; 31(19):3124-6. PubMed ID: 7150337
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of lactic acidosis with dichloroacetate in dogs.
    Park R; Arieff AI
    J Clin Invest; 1982 Oct; 70(4):853-62. PubMed ID: 6288773
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics of oral dichloroacetate in dogs.
    Maisenbacher HW; Shroads AL; Zhong G; Daigle AD; Abdelmalak MM; Samper IS; Mincey BD; James MO; Stacpoole PW
    J Biochem Mol Toxicol; 2013 Dec; 27(12):522-5. PubMed ID: 24038869
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Haemodialysis studies with dichloroacetate.
    Curry SH; Lorenz A; Henderson GN; Mars DR; Stacpoole PW
    Eur J Clin Pharmacol; 1991; 40(6):613-7. PubMed ID: 1884744
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The disposition of radioactivity after administration of the anthelminthic methyl-14C-5-cyclopropylcarbonyl-2-benzimidazole carbamate (ciclobendazole) to rats and dogs.
    Brodie RR; Mayo BC; Chasseaud LF; Hawkins DR
    Arzneimittelforschung; 1977; 27(3):593-8. PubMed ID: 577426
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of dichloroacetate in the treatment of hypoxic lactic acidosis in dogs.
    Graf H; Leach W; Arieff AI
    J Clin Invest; 1985 Sep; 76(3):919-23. PubMed ID: 4044835
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dichloroacetate, sodium: 3-month oral toxicity studies in rats and dogs.
    Katz R; Tai CN; Diener RM; McConnell RF; Semonick DE
    Toxicol Appl Pharmacol; 1981 Feb; 57(2):273-87. PubMed ID: 7222043
    [No Abstract]   [Full Text] [Related]  

  • 11. Effects of sodium dichloroacetate in awake, healthy, Yucatan miniature swine.
    Weingand KW; Fettman MJ; Phillips RW; Hand MS
    Am J Vet Res; 1986 Feb; 47(2):441-6. PubMed ID: 3513679
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics and disposition of the oxytocin receptor antagonist L-368,899 in rats and dogs.
    Thompson KL; Vincent SH; Miller RR; Colletti AE; Alvaro RF; Wallace MA; Feeney WP; Chiu SH
    Drug Metab Dispos; 1997 Oct; 25(10):1113-8. PubMed ID: 9321512
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics of dichloroacetate in adult patients with lactic acidosis.
    Henderson GN; Curry SH; Derendorf H; Wright EC; Stacpoole PW
    J Clin Pharmacol; 1997 May; 37(5):416-25. PubMed ID: 9156374
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Comparative effects of dichloroacetate and sodium bicarbonate on plasma lactic acid levels in experimentally produced hypoxia].
    Nakata F; Kemmotsu O; Tanaka R
    Masui; 1987 Jul; 36(7):1100-7. PubMed ID: 2824875
    [No Abstract]   [Full Text] [Related]  

  • 15. Concentrations of phenethylamine in dog following single doses and during intravenous self-administration.
    Cone EJ; Risner ME; Neidert GL
    Res Commun Chem Pathol Pharmacol; 1978 Nov; 22(2):211-32. PubMed ID: 734213
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma nicotine pharmacokinetics in dogs after intravenous administration: determination by radioimmunoassay.
    Monji N; Castro A
    Res Commun Chem Pathol Pharmacol; 1979 Feb; 23(2):267-77. PubMed ID: 461952
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Disposition and pharmacodynamics of dichloroacetate (DCA) and oxalate following oral DCA doses.
    Curry SH; Lorenz A; Chu PI; Limacher M; Stacpoole PW
    Biopharm Drug Dispos; 1991 Jul; 12(5):375-90. PubMed ID: 1878534
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A rapid microassay for dichloroacetate in serum by gel-permeation chromatography.
    Sakakihara Y; Nakamura G; Tokoeda Y; Abe T; Kamoshita S
    Eur J Clin Chem Clin Biochem; 1994 Feb; 32(2):79-83. PubMed ID: 8003581
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of dichloroacetate in the treatment of anoxic lactic acidosis in dogs.
    Sheikh A; Fleisher G; Delgado Paredes C; Caputo G; Schaible D; Egler J; Swedlow D
    Crit Care Med; 1986 Nov; 14(11):970-3. PubMed ID: 3021391
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics of HIV protease inhibitor DMP 323 in rats and dogs.
    Grubb MF; Wong YN; Burcham DL; Saxton PL; Quon CY; Huang SM
    Drug Metab Dispos; 1994; 22(5):709-12. PubMed ID: 7835221
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.